These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


403 related items for PubMed ID: 31233920

  • 1. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
    Song XD, Chen BB, He SF, Pan NL, Liao JX, Chen JX, Wang GH, Sun J.
    Eur J Med Chem; 2019 Oct 01; 179():26-37. PubMed ID: 31233920
    [Abstract] [Full Text] [Related]

  • 2. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents.
    Song XD, Kong X, He SF, Chen JX, Sun J, Chen BB, Zhao JW, Mao ZW.
    Eur J Med Chem; 2017 Sep 29; 138():246-254. PubMed ID: 28668477
    [Abstract] [Full Text] [Related]

  • 3. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
    Zheng Y, He L, Zhang DY, Tan CP, Ji LN, Mao ZW.
    Dalton Trans; 2017 Aug 29; 46(34):11395-11407. PubMed ID: 28813052
    [Abstract] [Full Text] [Related]

  • 4. Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents.
    Li Y, Liu B, Lu XR, Li MF, Ji LN, Mao ZW.
    Dalton Trans; 2017 Aug 29; 46(34):11363-11371. PubMed ID: 28812748
    [Abstract] [Full Text] [Related]

  • 5. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
    Pérez-Arnaiz C, Acuña MI, Busto N, Echevarría I, Martínez-Alonso M, Espino G, García B, Domínguez F.
    Eur J Med Chem; 2018 Sep 05; 157():279-293. PubMed ID: 30099251
    [Abstract] [Full Text] [Related]

  • 6. Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy.
    Wu N, Cao JJ, Wu XW, Tan CP, Ji LN, Mao ZW.
    Dalton Trans; 2017 Oct 10; 46(39):13482-13491. PubMed ID: 28951916
    [Abstract] [Full Text] [Related]

  • 7. Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands.
    Sanz-Villafruela J, Bermejo-Casadesus C, Zafon E, Martínez-Alonso M, Durá G, Heras A, Soriano-Díaz I, Giussani A, Ortí E, Tebar F, Espino G, Massaguer A.
    Eur J Med Chem; 2024 Oct 05; 276():116618. PubMed ID: 38972079
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, photophysical and anticancer properties of mitochondria-targeted phosphorescent cyclometalated iridium(III) N-heterocyclic carbene complexes.
    Li Y, Wang KN, He L, Ji LN, Mao ZW.
    J Inorg Biochem; 2020 Apr 05; 205():110976. PubMed ID: 31926377
    [Abstract] [Full Text] [Related]

  • 9. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
    Li Y, Liu B, Xu CX, He L, Wan YC, Ji LN, Mao ZW.
    J Biol Inorg Chem; 2020 Jun 05; 25(4):597-607. PubMed ID: 32232583
    [Abstract] [Full Text] [Related]

  • 10. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
    Zhang H, Tian L, Xiao R, Zhou Y, Zhang Y, Hao J, Liu Y, Wang J.
    Bioorg Chem; 2021 Oct 05; 115():105290. PubMed ID: 34426145
    [Abstract] [Full Text] [Related]

  • 11. Cyclometalated iridium(III) tetrazine complexes for mitochondria-targeted two-photon photodynamic therapy.
    Tan Z, Lin M, Liu J, Wu H, Chao H.
    Dalton Trans; 2024 Aug 06; 53(31):12917-12926. PubMed ID: 39028267
    [Abstract] [Full Text] [Related]

  • 12. Cyclometalated iridium(iii) complexes for mitochondria-targeted combined chemo-photodynamic therapy.
    Qin WW, Pan ZY, Cai DH, Li Y, He L.
    Dalton Trans; 2020 Mar 17; 49(11):3562-3569. PubMed ID: 32123890
    [Abstract] [Full Text] [Related]

  • 13. Amphiphilic Gemini Iridium(III) Complex as a Mitochondria-Targeted Theranostic Agent for Tumor Imaging and Photodynamic Therapy.
    Yi S, Lu Z, Zhang J, Wang J, Xie Z, Hou L.
    ACS Appl Mater Interfaces; 2019 May 01; 11(17):15276-15289. PubMed ID: 30968687
    [Abstract] [Full Text] [Related]

  • 14. Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules.
    Zhang WY, Yi QY, Wang YJ, Du F, He M, Tang B, Wan D, Liu YJ, Huang HL.
    Eur J Med Chem; 2018 May 10; 151():568-584. PubMed ID: 29656200
    [Abstract] [Full Text] [Related]

  • 15. Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro.
    Aksakal NE, Tanrıverdi Eçik E, Kazan HH, Yenilmez Çiftçi G, Yuksel F.
    Photochem Photobiol Sci; 2019 Aug 01; 18(8):2012-2022. PubMed ID: 31282525
    [Abstract] [Full Text] [Related]

  • 16. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer agents.
    Xiong K, Chen Y, Ouyang C, Guan RL, Ji LN, Chao H.
    Biochimie; 2016 Jun 01; 125():186-94. PubMed ID: 27039888
    [Abstract] [Full Text] [Related]

  • 17. Neutral iridium(iii) complexes bearing BODIPY-substituted N-heterocyclic carbene (NHC) ligands: synthesis, photophysics, in vitro theranostic photodynamic therapy, and antimicrobial activity.
    Liu B, Monro S, Jabed MA, Cameron CG, Colón KL, Xu W, Kilina S, McFarland SA, Sun W.
    Photochem Photobiol Sci; 2019 Oct 09; 18(10):2381-2396. PubMed ID: 31432864
    [Abstract] [Full Text] [Related]

  • 18. Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents.
    Peng W, Hegazy AM, Jiang N, Chen X, Qi HX, Zhao XD, Pu J, Ye RR, Li RT.
    J Inorg Biochem; 2020 Feb 09; 203():110909. PubMed ID: 31689591
    [Abstract] [Full Text] [Related]

  • 19. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J, Tian Z, Xu Z, Zhang S, Feng Y, Zhang L, Liu Z.
    Dalton Trans; 2018 Nov 13; 47(44):15772-15782. PubMed ID: 30357192
    [Abstract] [Full Text] [Related]

  • 20. A Nanoencapsulated Ir(III)-Phthalocyanine Conjugate as a Promising Photodynamic Therapy Anticancer Agent.
    Bonelli J, Ortega-Forte E, Vigueras G, Follana-Berná J, Ashoo P, Abad-Montero D, Isidro N, López-Corrales M, Hernández A, Ortiz J, Izquierdo-García E, Bosch M, Rocas J, Sastre-Santos Á, Ruiz J, Marchán V.
    ACS Appl Mater Interfaces; 2024 Jul 31; 16(30):38916-38930. PubMed ID: 39041453
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.